Rgenix is a privately-held clinical-stage biopharmaceutical company developing first-in-class drugs that target key pathways in cancer progression.

310 E 67th St, Suite 1-12‎ New York, NY
(646) 856-9261
info@rgenix.com

Events

New York, NY – November 04, 2020 - RGENIX, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, announced today that CEO Masoud Tavazoie, M.D., Ph.D., will present at the 2020 Stifel Virtual Healthcare Conference at 8:40 A.M. EST on November 16, 2020.   To view this virtual presentation live, register for the event here.   Links

H.C. Wainwright 22nd Annual Global Investment Conference

Canaccord Genuity 40th Annual Growth Conference

2020 Wedbush PacGrow Healthcare Conference

BTIG Virtual Biotechnology Conference 2020

LifeSci Partners Summer Symposium

New York, NY – Aug 05, 2020 - RGENIX, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, announced today that it has been selected to present at multiple virtual healthcare investor conferences taking place during the month of August.   These conferences include:   LifeSci Partners Summer Symposium  August 5, 2020